Filter trials by:

Year

Indication

Phase

Type

Indication: Overactive Bladder

A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder.

Year: 2013
Type: Pharmaceutical - Other
Phase: III
Indication: Overactive Bladder

A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Multi-center Study to Evaluate the Long-Term Safety and Efficacy of Combination of Solifenacin Succinate with Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in Subjects with Overactive Bladder.

Year: 2013
Type: Pharmaceutical - Other
Phase: III
Indication: Overactive Bladder